524731 — Jenburkt Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapHigh Flyer

Annual balance sheet for Jenburkt Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	R2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	584	561	466	495	740
Net Total Accounts Receivable
Net Total Receivables	186	146	179	215	252
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	895	800	759	811	1,097
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	110	104	113	112	112
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,041	1,212	1,429	1,418	1,651
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	198	180	213	158	164
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	241	227	256	194	202
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	800	985	1,174	1,224	1,449
Total Liabilities & Shareholders' Equity	1,041	1,212	1,429	1,418	1,651
Total Common Shares Outstanding